Double pterygium of left eye
ICD-10 H11.032 is a billable code used to indicate a diagnosis of double pterygium of left eye.
Double pterygium of the left eye is characterized by the presence of two pterygia, which are benign growths of conjunctival tissue that extend onto the cornea. These growths typically arise due to chronic exposure to UV light, dust, and wind, leading to conjunctival inflammation and fibrovascular proliferation. Clinically, patients may present with symptoms such as redness, irritation, and visual disturbances, particularly if the pterygia encroach upon the visual axis. Anatomically, the conjunctiva, sclera, and cornea are involved, with the pterygium originating from the conjunctival tissue and extending onto the corneal surface. Disease progression can lead to increased discomfort and potential astigmatism as the pterygia grow. Diagnostic considerations include a thorough eye examination, where the ophthalmologist assesses the size, location, and impact of the pterygia on vision. Imaging may not be necessary, but documentation of symptoms and visual acuity is crucial for treatment planning and coding purposes.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H11.032 specifically covers double pterygium of the left eye, which involves two distinct pterygia affecting the conjunctiva and cornea. It is important to differentiate this from single pterygium codes and other conjunctival disorders.
H11.032 should be used when there are two pterygia present on the left eye, as opposed to H11.031, which is for a single pterygium. Accurate diagnosis and documentation of both lesions are essential for correct code selection.
Documentation must include a detailed eye examination report, noting the presence of two pterygia, their size, location, and any associated symptoms. Visual acuity measurements and treatment plans should also be included to support the medical necessity of the diagnosis.
